Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Improving outcomes in hypertensive patients: Focus on adherence and persistence with antihypertensive therapy
The Journal of Clinical Hypertension, 06/25/09
Elliott WJ et al. – A review on outcomes in hypertensive pts reports improved outcomes with a focus on adherence and persistence with antihypertensive therapy.
Methods- Review on outcomes in hypertension
- Blood pressure (BP) control rates among treated pts in actual clinical practice are less than optimal despite effective BP control reducing risk of cardiovascular events in hypertension
- Costs of drugs and medical care are key but difficult to estimate both in clinical trials and general clinical practice
- Drug-taking behavior—adherence and persistence with antihypertensive regimens—influences BP control rates
- Rates vary greatly among antihypertensive classes based on many factors affecting pt adherence and persistence, including drug efficacy and tolerability
- Medications with fewer adverse effects associated with increased adherence and lower discontinuation rates
- Widespread use of these drugs (and generic or low-cost formulations) may lead to better long-term BP control and fewer cardiovascular events
Related Articles
Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients
Journal of Electrocardiology, 10/29/09
Relevance Score: 66%
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study
Journal of Hypertension, 10/26/09
Relevance Score: 66%
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Circulation, 10/08/09
Relevance Score: 66%
FDA approves Twynsta a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours
Boehringer Ingelheim, 10/20/09
Relevance Score: 65%
Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study
American Journal of Cardiovascular Drugs, 10/07/09
Relevance Score: 65%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
British Medical Journal, 12/07/09
Long-Term Stability of Cardiovascular and Catecholamine Responses to Stress Tests. An 18-Year Follow-Up Study
Hypertension, 12/07/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


